Common Blood Pressure Drug may Increase Risk of Skin Cancer

Common Blood Pressure Drug may Increase Risk of Skin Cancer

Researchers from The University of Southern Denmark on December 5, 2017, revealed that a commonly used blood pressure medicine may increase the risk of skin cancer. The findings revealed that using medicines with hydrochlorothiazide drug may increase the risk of developing squamous cell carcinoma up to seven times.

Researchers from The University of Southern Denmark had previously found that antihypertensive medicine containing hydrochlorothiazide, which is the most commonly used drugs worldwide can increase the risk of lip cancer. In a recent study, they identified another. In the study published in Journal of the American Association of Dermatology, researchers from the same university identified link between the use of hypertension medicine and the chance of developing skin cancer identified.

Hydrochlorothiazide is one of the most commonly used antihypertensive drugs worldwide. It is a thiazide diuretic that helps in prevention of salt absorption and fluid retention by body. A study had nearly 80,000 participants who claimed that long term use of drugs that help to lower high blood pressure may increase the risk of developing skin cancer. According to a study, hydrochlorothiazide makes the skin more vulnerable to damage from UV sun rays.

“We knew that hydrochlorothiazide made the skin more vulnerable to damage from the sun’s UV rays, but what is new and also surprising is that long term use of this blood pressure medicine leads to such a significant increase in the risk of skin cancer,” said Anton Pottegard, associate professor at the University of Southern Denmark.

Hydrochlorothiazide is frequently used for the treatment of congestive heart failure, symptomatic edema, diabetes insipidus, and renal tubular acidosis. It is used for the prevention of kidney stones in patients with high levels of calcium in their urine. Pottegard suggested that one should not interrupt the treatment without consulting the doctor, as hydrochlorothiazide is an effective and otherwise safe treatment for most patients.

You may be interested

Business

Tricks Used by Insurance Companies to Deny Legit Claims

media - December 10, 2018

Health insurance companies strategize in making more and more money by paying out as little as possible. Many times, they deny legitimate claims which are covered under…

New Study Suggests Typical Use of Sunscreens Offers Less Sun Protection
Business
Business

New Study Suggests Typical Use of Sunscreens Offers Less Sun Protection

Mohit Joshi - December 10, 2018

Researchers from King's College London revealed that use of sunscreen offers less than half the sun protection as users apply more thinly than manufacturers recommend. In a…

Tamoxifen Market: Segmented by Application and Geography Trends, Growth and Forecasts 2026
Healthcare
Healthcare

Tamoxifen Market: Segmented by Application and Geography Trends, Growth and Forecasts 2026

Albert R - December 10, 2018

Tamoxifen Market report is a research database spread across various pages with multiple tables and figures in it. The research covers a valuable source of perceptive information…

Most from this category